mid-ventricular level (N = 200 for each condition). Apoptic and mitotic cardiomyocytes were assessed using the ApopTag in situ apoptosis detection kit (Serologicals Corp.) and H3P antibody (Upstate Biotechnology), respectively, plus counter-staining with FITC-conjugated MF20 antibody to sarcomeric MHC (N = 10,000 for each condition). For transmission electron microscopy, samples were prepared by standard procedures, sectioned using a RMC MT6000 ultramicrotome, and visualized using a Hitachi H7500 electron microscope and 2Kx2K Gatan CCD camera.
Gene Expression
RNA was isolated with Trizol (Invitrogen) and purified using RNeasy columns (Qiagen). For expression profiling, samples were labeled with biotinylated nucleotides by reverse transcription, hybridized to MG U74Av2 arrays (Affymetrix), and stained with streptavidin-phycoerythrin.
Fluorescence intensities were captured with a an Affimetrix GeneArray 2500 Scanner, quantified with Affymetrix Microarray Suite 5.0, and analyzed using GeneSpring™ version 6.0 (Silicon Genetics) and dChip2004 (Li and Wong, 2001 ). Based on the microarray results, real-time quantitative RT-PCR (7700 Sequence Detection System, Applied Biosystems) was performed to confirm selected findings and survey additional pertinent genes. TaqMan primers and probes were designed using Primer Express software version 1.0 (Applied Biosystems).
Mitochondrial Enzyme and Respiration Assays
Hearts from 4 week-old MAT1 CKO mice and littermate controls were homogenized on ice in 9 vol of 150 mM sucrose, 2 mM EDTA, 100 mM Tris-HCl, pH 7.45, using a motorized homogenizer (Glas-Col, Terre Haute, IN), centrifuged at 700 x g for 20 min, and the supernatant was collected. Citrate synthase activity was assayed in 1 mM 5,5'-dithiobis(2-nitrobenzoic acid), 10 mM acetyl CoA, 10mM oxaloacetate, as the increase in absorbance over 2 min at 412 nm (Srere, 1969) . Complex IV (cytochrome oxidase) activity was determined in 0.01 M potassium phosphate, pH 7.0, 1% reduced cytochrome c, as the decrease in absorbance over 3 min at 550 nm (Yonetani, 1967) . Complex II (succinate dehydrogenase) activity was assayed in 0.1 M potassium phosphate, pH 7.0, 400 mM succinate, 10 mM KCN, 0.015% 2,6-dichlorophenol-indophenol as the decrease in absorbance over 1 min at 600 nm (King, 1967) . Complex II + III (succinate cytochrome c reductase) activity was assayed in 0.1 M potassium phosphate, pH 7.5, 30 mM succinate, 10 mM KCN, 1 mM cytochrome c as the increase in absorbance over 2 min at 550 nm (King, 1967) . Complex I (NADH dehydrogenase) activity was assayed in 0.1 potassium phosphate buffer, pH 7.5, 0.01 M K 3 Fe(CN) 6 , 2 mM NADH, as the decrease in absorbance over 2.5 min at 340 nm (King and Howard, 1967) .
Complex I + III activity (NADH cytochrome c reductase) was measured via the increase in absorbance at 550 nm. The reaction mixture contained 0.1 M potassium phosphate, pH 7.5, 2 mM NADH, 10 mM KCN, and 1 mM cytochrome c. The reaction was initiated by the addition of 2 mM NADH and monitored for 1 min; rotenone was then added to a final concentration of 10 µM and the activity measured for an additional 2 min. Complex I + III activity was determined as the rotenone-sensitive NADH:cytochrome c reductase activity (King and Howard, 1967) .
For mitochondrial respiration (Trounce et al., 1996) , mitochondria were isolated from the liver and heart of CKO and control mice. One of two substrates was added to the respiration 
Ventricular Pressure
Ventricular hemodynamics were determined in isolated mouse hearts, as described (Belke et al., 2002; Boudina et al., 2005) . Hearts of four week-old control and CKO mice were allowed to stabilize for 30 min, before acquisition of baseline hemodynamic parameters at 2 mM Ca 2+ . The perfusate calcium concentration was then increased to 4 mM, and contractile parameters were re-measured after a further 20 min. As substrate, the hearts were perfused with glucose (5 mM) plus palmitate (0.4 mM).
Plasmids and Transfection
Expression vectors for human PGC-1α,  α L2/3A, GAL4 DBD, GAL4 DBD-ERRαLBD, GAL4 DBD-PGC-1α, GAL4 DBD-PGC-1β (Knutti et al., 2000; Knutti et al., 2001 ) and the reporter genes pATPsynβ/-385Luc, pCytc/-686Luc, pCytc/-686Luc 2xERREmt, pCytc/-686Luc
NRF1Remt (Schreiber et al., 2004) , pGK-1 (Webb et al., 1995) , Fos-luc (SRE2-tk80-luc) (Janknecht et al., 1993) , and Hsp70-luc (Sano et al., 2004) were previously described. Other plasmids were kindly provided by the following investigators: pcDNA3RARα and pRARE-tk-luc, J. Wong; (PPRE) 3 -tk-luc and pcDNA3ERRα, D. Kelly (Lehman et al., 2000; Huss et al., 2002) ; pcDNA3PPARα and pcDNA3RXRα, P. Barger; PGC-1β, B. Spiegelman (Lin et al., 2005) .
Luciferase activity was determined using the Dual-Luciferase Reporter Assay System (Promega) and a Monolight 2010 luminometer
GST Pull-down and Coimmunoprecipitation Assays
Bacterially expressed GST proteins were immobilized on gluthathione-Sepharose 4B resin (Amersham Bioscience). In vitro transcription and translation were performed using the TNT Coupled Reticulocyte Lysate system (Promega). Briefly, 1µg of template DNA was incubated with TNT reaction mixture at 30°C for 90 min in the presence of [ 35 S]methionine. In vitro translation products were incubated with GST-protein beads for 1 hr at room temperature.
Bound proteins were subjected to SDS-PAGE and detected by autoradiography. HepG2 cell nuclear extract was prepared as described (Shimizu et al., 2005) 
